Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Otovowen vs placebo for prevention of recurrent acute otitis media in children
DRKS00004569Phase 3Completed
- Sponsor
- Weber & Weber
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute otitis media (AOM) and upper respiratory infection (URI) comparing Otovowen with Placebo (2 arms). Started Jan 2014; status: completed.
02
Drugs
Otovowen
03
Conditions
acute otitis media (AOM)upper respiratory infection (URI)
Beyond the preview
Go deeper on DRKS00004569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00004569.